Literature DB >> 17826949

Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.

Andrea Fekete1, Lilla Soos, Zoltan Szekanecz, Zoltan Szabo, Peter Szodoray, Sandor Barath, Gabriella Lakos.   

Abstract

Naïve and memory B- and T-cell subsets were examined with three-color flow cytometry in the peripheral blood of patients with rheumatoid arthritis (RA) in comparison with healthy controls, and their association with disease duration, activity and autoantibodies was investigated in order to reveal potential imprints of antigen-specific immune response in RA. The B-cell population consisted of significantly less naïve (58.1+/-3.9% versus 68.7+/-3.7%; p=0.04), and more IgD-/CD27+ memory B cells (19.6+/-2.1% versus 13.7+/-2.1%; p=0.04) compared to healthy subjects. In addition, strong correlation was demonstrated between disease duration and the percentage of memory B cells (p<0.0001). Increased CD8+ terminally differentiated effector memory/central memory T-cell ratio (1.35+/-0.35 versus 0.84+/-0.24) was also detected in RA patients compared with controls, which also correlated with the duration of RA (p=0.005). The frequency of memory B cells and CD8+ effector memory T cells correlated with the proportion of CD4+ effector memory lymphocytes, suggesting cooperation between immune cells. Our results reflect disturbances in B- and T-cell homeostasis characterized by the accumulation of memory B cells and a shift towards CD8+ terminally differentiated effector memory T cells in RA, suggesting ongoing, antigen-driven immune response and accelerated differentiation of B and T lymphocytes into effector cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826949     DOI: 10.1016/j.jaut.2007.07.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  25 in total

1.  Identifying genetic loci and spleen gene coexpression networks underlying immunophenotypes in BXD recombinant inbred mice.

Authors:  Rachel M Lynch; Sudhir Naswa; Gary L Rogers; Stephen A Kania; Suchita Das; Elissa J Chesler; Arnold M Saxton; Michael A Langston; Brynn H Voy
Journal:  Physiol Genomics       Date:  2010-02-23       Impact factor: 3.107

2.  B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.

Authors:  Yuki Moritoki; Zhe-Xiong Lian; Keith Lindor; Joseph Tuscano; Koichi Tsuneyama; Weici Zhang; Yoshiyuki Ueno; Robert Dunn; Marilyn Kehry; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

3.  Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents.

Authors:  Jin-Ling Shu; Xian-Zheng Zhang; Le Han; Feng Zhang; Yu-Jing Wu; Xiao-Yu Tang; Chen Wang; Yu Tai; Qing-Tong Wang; Jing-Yu Chen; Yan Chang; Hua-Xun Wu; Ling-Ling Zhang; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2018-11-16       Impact factor: 6.150

4.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

5.  RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.

Authors:  Wujiang Liu; Barry R Deyoung; Xiaohong Chen; David P Evanoff; Yi Luo
Journal:  J Autoimmun       Date:  2007-12-26       Impact factor: 7.094

6.  Quantitative alterations of CD8+ T cells in juvenile idiopathic arthritis patients in remission.

Authors:  Martina Prelog; Nora Schwarzenbrunner; Elisabeth Tengg; Michaela Sailer-Höck; Hannelore Kern; Lothar Bernd Zimmerhackl; Juergen Brunner
Journal:  Clin Rheumatol       Date:  2008-12-18       Impact factor: 2.980

7.  BF02, a recombinant TNFR2 fusion protein, alleviates adjuvant arthritis by regulating T lymphocytes in rats.

Authors:  Shan-shan Song; Bei Huang; Qing-tong Wang; Yu-jing Wu; Jing-jing Fu; Yun-fang Zhang; Yan Chang; Jing-yu Chen; Hua-xun Wu; Di Wang; Ling-ling Zhang; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2013-02-04       Impact factor: 6.150

Review 8.  The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses.

Authors:  S Modi; M Soejima; M C Levesque
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

9.  Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor.

Authors:  M Margarida Souto-Carneiro; Vijayabhanu Mahadevan; Kazuki Takada; Ruth Fritsch-Stork; Toshihiro Nanki; Margaret Brown; Thomas A Fleisher; Mildred Wilson; Raphaela Goldbach-Mansky; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2009-06-05       Impact factor: 5.156

Review 10.  Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.

Authors:  Maria J Leandro
Journal:  Arthritis Res Ther       Date:  2009-10-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.